Compare Cassava Sciences Inc (FLNA) vs McDonald's Corp (MCD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs McDonald's Corp — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while McDonald's Corp trades at $272.16 (market cap $188.25B). The key difference: McDonald's Corp is far larger — about 3542.5× Cassava Sciences Inc's market cap, and McDonald's Corp pays a 2.81% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | MCD | |
|---|---|---|
Market Cap | $53.14M | $188.25B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $341.06 |
52-Week Low | $1.09 | $264.54 |
Enterprise Value | -$33.43M | $241.96B |
Volume | — | 2,230,036 |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →
